PDL BIOPHARMA INC's ticker is and the CUSIP is 69329Y904. A total of 3 filers reported holding PDL BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $63,000 | +103.2% | 258 | +158.0% | 0.00% | – |
| Q3 2020 | $31,000 | – | 100 | -38.7% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 163 | +425.8% | 0.00% | – |
| Q1 2020 | $8,000 | -55.6% | 31 | -44.6% | 0.00% | – |
| Q4 2019 | $18,000 | +50.0% | 56 | -6.7% | 0.00% | – |
| Q3 2019 | $12,000 | +200.0% | 60 | +328.6% | 0.00% | – |
| Q2 2019 | $4,000 | -84.6% | 14 | -80.3% | 0.00% | – |
| Q1 2019 | $26,000 | -10.3% | 71 | -29.7% | 0.00% | – |
| Q4 2018 | $29,000 | -9.4% | 101 | -17.2% | 0.00% | – |
| Q3 2018 | $32,000 | +3100.0% | 122 | +2340.0% | 0.00% | – |
| Q2 2018 | $1,000 | -92.9% | 5 | -98.6% | 0.00% | -100.0% |
| Q1 2018 | $14,000 | +1300.0% | 357 | +142.9% | 0.00% | – |
| Q4 2017 | $1,000 | -66.7% | 147 | +21.5% | 0.00% | – |
| Q3 2017 | $3,000 | -40.0% | 121 | +14.2% | 0.00% | – |
| Q2 2017 | $5,000 | – | 106 | +381.8% | 0.00% | – |
| Q1 2017 | $0 | – | 22 | -92.1% | 0.00% | – |
| Q4 2016 | $0 | – | 277 | +96.5% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 141 | -38.7% | 0.00% | – |
| Q2 2016 | $2,000 | +100.0% | 230 | +233.3% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 69 | -52.1% | 0.00% | – |
| Q4 2015 | $1,000 | – | 144 | +166.7% | 0.00% | – |
| Q3 2015 | $0 | – | 54 | +5300.0% | 0.00% | – |
| Q2 2015 | $0 | – | 1 | -85.7% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 7 | -92.6% | 0.00% | – |
| Q4 2014 | $1,000 | – | 95 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 122 | $32,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 400 | $1,000 | 0.00% |